Skip to content

Homeopathic medicine Hypericum in treating fingertip injury

Efficacy of Hypericum perforatum 200CH in preventing and treating fingertip puncture site pain and tenderness: A double-blind, randomized, placebo-controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/064977
Enrollment
90
Registered
2024-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hypericum perforatum 200CH in centesimal potencies: Intervention is planned as administering three doses of Hypericum perforatum 200CH the night before the practical, half an hour prior

Sponsors

D N De Homoeopathic Medical College Hospita
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants who are healthy with no major diseases 2. Age 18-27 years 3. Either sex or transgender 4. History of being immunized against tetanus 5. Providing written informed consent voluntarily to participate

Exclusion criteria

Exclusion criteria: 1. Subjects with untreated or active malignancy or recovered from malignancy. 2. Vulnerable populations ? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 3. Self-reported immune compromised states. 4. Diagnosed unstable psychiatric illness or other uncontrolled or life-threatening illness affecting the quality of life or any organ failure. 5. Substance abuse and/or dependence. 6. Any blood-related disorder.

Design outcomes

Primary

MeasureTime frame
Time to complete resolution of pain and tenderness at the puncture siteTimepoint: Initially twice at 6 hours intervals on day 0 (immediately after the puncture, and 6 hours after the puncture), and subsequently once on day 1, day 2, day 3, and day 4

Secondary

MeasureTime frame
0-100 mm visual analogue scales (VAS) measuring the intensity of puncture site pain and tenderness in both groups, measured for up to 5 days.Timepoint: Initially twice at 6 hours intervals on day 0 (immediately after the puncture, and 6 hours after the puncture), and subsequently once on day 1, day 2, day 3, and day 4

Countries

India

Contacts

Public ContactSoumyadeep Maity

D N De Homoeopathic Medical College and Hospital

dibyendu83.mandal@gmail.com9143124224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026